Baroda BNP Paribas Health and Wellness Fund holds 32 instruments (96.61% equity), led by Sun Pharmaceutical Industries Limited (8.82%), Torrent Pharmaceuticals Limited (8.58%) and Divi's Laboratories Limited (6.66%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Baroda BNP Paribas Health and Wellness Fund, managed by Baroda BNP Paribas Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 32 instruments with an equity allocation of 96.61%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Baroda BNP Paribas Health and Wellness Fund's top 10 holdings account for 58.87% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 91.83% of net assets, spread across 4 sectors in total. Since its 30 June 2026 disclosure, the fund added 1 new position and exited 2 positions, with Torrent Pharmaceuticals Limited seeing the largest move (+3.15pp to 8.58%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Torrent Pharmaceuticals Limited | 5.43% → 8.58% | ▲ +3.15 |
| Divi's Laboratories Limited | 5.35% → 6.66% | ▲ +1.31 |
| Sun Pharmaceutical Industries Limited | 7.58% → 8.82% | ▲ +1.24 |
| Dr. Lal Path Labs Ltd. | 2.53% → 3.12% | ▲ +0.59 |
| Apollo Hospitals Enterprise Limited | 4.87% → 5.35% | ▲ +0.48 |
| Abbott India Limited | 2.07% → 2.41% | ▲ +0.34 |
| Concord Biotech Limited | 1.74% → 2.05% | ▲ +0.31 |
| Glenmark Pharmaceuticals Limited | 3.19% → 3.44% | ▲ +0.25 |
| Fortis Healthcare Limited | 4.32% → 4.55% | ▲ +0.23 |
| Aurobindo Pharma Limited | 2.85% → 3.04% | ▲ +0.19 |
| Stock | Weight | Change |
|---|---|---|
| Emcure Pharmaceuticals Limited | 3.6% → 2.46% | ▼ -1.14 |
| Laurus Labs Limited | 6.31% → 5.24% | ▼ -1.07 |
| Ajanta Pharma Limited | 1.95% → 1.4% | ▼ -0.55 |
| Acutaas Chemicals Limited | 2.3% → 2.15% | ▼ -0.15 |
| Dr. Reddy's Laboratories Limited | 1.23% → 1.11% | ▼ -0.12 |
| Nephrocare Health Services Limited | 1.84% → 1.74% | ▼ -0.1 |
| Inventurus Knowledge Solutions Limited | 1.52% → 1.42% | ▼ -0.1 |
| Lupin Limited | 6.56% → 6.46% | ▼ -0.1 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Baroda BNP Paribas Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.